Chemotherapy for Biliary Tract Cancer in 2021

por Sasaki, Takashi, Takeda, Tsuyoshi, Okamoto, Takeshi, Ozaka, Masato, Sasahira, Naoki
Publicado en J Clin Med (2021)

Improvement of Treatment Outcomes for Metastatic Pancreatic Cancer: A Real-world Data Analysis

por SASAKI, TAKASHI, KANATA, RYO, YAMADA, IKUHIRO, MATSUYAMA, MASATO, OZAKA, MASATO, SASAHIRA, NAOKI
Publicado en In Vivo (2019)

Evaluation of circulating tumor DNA as a biomarker in pancreatic cancer with liver metastasis

por Uesato, Yasunori, Sasahira, Naoki, Ozaka, Masato, Sasaki, Takashi, Takatsuki, Mitsuhisa, Zembutsu, Hitoshi
Publicado en PLoS One (2020)

Phase II study of reintroduction of oxaliplatin for advanced colorectal cancer in patients previously treated with oxaliplatin and irinotecan: RE-OPEN study

por Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Matsusaka, Satoshi, Shinozaki, Eiji, Ozaka, Masato, Ogura, Mariko, Yamaguchi, Toshiharu
Publicado en Drug Des Devel Ther (2015)

Anticoagulant therapy for venous thromboembolism detected by Doppler ultrasound in patients with metastatic colorectal cancer receiving bevacizumab

por Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Shinozaki, Eiji, Matsusaka, Satoshi, Ozaka, Masato, Ogura, Mariko, Chin, Keisho, Yamaguchi, Toshiharu
Publicado en Onco Targets Ther (2015)

A phase I/II study of biweekly capecitabine and irinotecan plus bevacizumab as second-line chemotherapy in patients with metastatic colorectal cancer

por Suenaga, Mitsukuni, Mizunuma, Nobuyuki, Matsusaka, Satoshi, Shinozaki, Eiji, Ozaka, Masato, Ogura, Mariko, Chin, Keisho, Yamaguchi, Toshiharu
Publicado en Drug Des Devel Ther (2015)

Diagnostic yield of endoscopic ultrasound-guided tissue acquisition for small solid pancreatic lesions

por Mie, Takafumi, Sasaki, Takashi, Kanata, Ryo, Furukawa, Takaaki, Takeda, Tsuyoshi, Kasuga, Akiyoshi, Matsuyama, Masato, Ozaka, Masato, Sasahira, Naoki
Publicado en Endosc Int Open (2020)

Novel risk factors for recurrent biliary obstruction and pancreatitis after metallic stent placement in pancreatic cancer

por Takeda, Tsuyoshi, Sasaki, Takashi, Mie, Takafumi, Furukawa, Takaaki, Kanata, Ryo, Kasuga, Akiyoshi, Matsuyama, Masato, Ozaka, Masato, Sasahira, Naoki
Publicado en Endosc Int Open (2020)

Diagnostic yield of endoscopic ultrasound-guided tissue acquisition for small solid pancreatic lesions

por Mie, Takafumi, Sasaki, Takashi, Kanata, Ryo, Furukawa, Takaaki, Takeda, Tsuyoshi, Kasuga, Akiyoshi, Matsuyama, Masato, Ozaka, Masato, Sasahira, Naoki
Publicado en Endosc Int Open (2020)

Grade 3/4 neutropenia is a limiting factor in second-line FOLFIRI following FOLFOX4 failure in elderly patients with metastatic colorectal cancer

por KUBOKI, YASUTOSHI, MIZUNUMA, NOBUYUKI, OZAKA, MASATO, OGURA, MARIKO, SUENAGA, MITSUKUNI, SHINOZAKI, EIJI, MATSUSAKA, SATOSHI, CHIN, KEISHOU, MATSUURA, MASAAKI, HATAKE, KIYOHIKO
Publicado 2011

Ultrasound-guided vs endoscopic ultrasound-guided fine-needle aspiration for pancreatic cancer diagnosis

por Matsuyama, Masato, Ishii, Hiroshi, Kuraoka, Kensuke, Yukisawa, Seigo, Kasuga, Akiyoshi, Ozaka, Masato, Suzuki, Sho, Takano, Kouichi, Sugiyama, Yuko, Itoi, Takao
Publicado 2013

Does anti-p53 antibody status predict for clinical outcomes in metastatic colorectal cancer patients treated with fluoropyrimidine, oxaliplatin, plus bevacizumab as first-line chem...

por Osumi, Hiroki, Shinozaki, Eiji, Suenaga, Mitsukuni, Kumekawa, Yosuke, Ogura, Mariko, Ozaka, Masato, Matsusaka, Satoshi, Chin, Keisho, Yamamoto, Noriko, Mizunuma, Nobuyuki
Publicado en BMC Cancer (2015)

Two Cases of Long-Term Survival of Advanced Colorectal Cancer with Synchronous Lung Metastases Treated with mFOLFOX6/XELOX + Bevacizumab

por Ushida, Yuta, Shinozaki, Eiji, Chin, Keisho, Suenaga, Mitsukuni, Takahari, Daisuke, Ozaka, Masato, Ogura, Mariko, Ichimura, Takashi, Wakatsuki, Takeru, Yamaguchi, Kensei
Publicado en Case Rep Oncol (2018)

Adherence to the guidelines and the pathological diagnosis of high-risk gastrointestinal stromal tumors in the real world

por Nishida, Toshirou, Sakai, Yoshiharu, Takagi, Masakazu, Ozaka, Masato, Kitagawa, Yuko, Kurokawa, Yukinori, Masuzawa, Toru, Naito, Yoichi, Kagimura, Tatsuo, Hirota, Seiichi
Publicado en Gastric Cancer (2019)

Prospective study of EUS-guided tissue acquisition with a 20G core biopsy needle with a forward bevel for solid pancreatic mass

por Kanata, Ryo, Sasaki, Takashi, Matsuyama, Masato, Ishigaki, Kazunaga, Yamada, Ikuhiro, Ozaka, Masato, Takano, Koichi, Takazawa, Yutaka, Ishizuka, Naoki, Sasahira, Naoki
Publicado en Medicine (Baltimore) (2021)

Risk factors for severe neutropenia in pancreatic cancer patients treated with gemcitabine/nab-paclitaxel combination therapy

por Ito, Genta, Kawakami, Kazuyoshi, Aoyama, Takeshi, Yokokawa, Takashi, Nakamura, Masashi, Ozaka, Masato, Sasahira, Naoki, Hashiguchi, Masayuki, Kizaki, Hayato, Hama, Toshihiro, Hori, Satoko
Publicado en PLoS One (2021)

Retrospective study of RAS/PIK3CA/BRAF tumor mutations as predictors of response to first-line chemotherapy with bevacizumab in metastatic colorectal cancer patients

por Nakayama, Izuma, Shinozaki, Eiji, Matsushima, Tomohiro, Wakatsuki, Takeru, Ogura, Mariko, Ichimura, Takashi, Ozaka, Masato, Takahari, Daisuke, Suenaga, Mitsukuni, Chin, Keisho, Mizunuma, Nobuyuki, Yamaguchi, Kensei
Publicado en BMC Cancer (2017)

Integrated communication support program for oncologists, caregivers and patients with rapidly progressing advanced cancer to promote patient-centered communication: J-SUPPORT 1904...

por Fujimori, Maiko, Sato, Ayako, Jinno, Sayaka, Okusaka, Takuji, Yamaguchi, Takuhiro, Ikeda, Masafumi, Ueno, Makoto, Ozaka, Masato, Takayama, Yukiko, Miyaji, Tempei, Majima, Yoshiyuki, Uchitomi, Yosuke
Publicado en BMJ Open (2020)

Early hypertension is associated with better clinical outcomes in gastric cancer patients treated with ramucirumab plus paclitaxel

por Fukuda, Naoki, Takahari, Daisuke, Wakatsuki, Takeru, Osumi, Hiroki, Nakayama, Izuma, Matsushima, Tomohiro, Ichimura, Takashi, Ogura, Mariko, Ozaka, Masato, Suenaga, Mitsukuni, Shinozaki, Eiji, Chin, Keisho, Yamaguchi, Kensei
Publicado en Oncotarget (2018)

Influence of initial dose intensity on efficacy of FOLFIRINOX in patients with advanced pancreatic cancer

por Kobayashi, Satoshi, Ueno, Makoto, Omae, Katsuhiro, Kuramochi, Hidekazu, Terao, Masato, Mizuno, Nobumasa, Ozaka, Masato, Ueno, Hideki, Uesugi, Kazuhiro, Kobayashi, Noritoshi, Kobayashi, Marina, Todaka, Akiko, Fukutomi, Akira
Publicado en Oncotarget (2019)